Premarket Gainer
HOTH Hoth Therapeutics2.18-0.03-1.4%
Premarket:2.96+0.78 (+35.8%)
Hoth Therapeutics Announces Positive Preclinical Results for Novel COVID-19 Therapeutic
PRNewswireTue, 23-Mar 8:01 AM
Premarket Gainer
HOTH Hoth Therapeutics1.64+0.06+3.8%
Premarket:2.30+0.66 (+40.2%)
Hoth Therapeutics Announces Production of HT-001 for Cancer Treatment
PRNewswireThu, 31-Dec 8:01 AM